Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CBRS vs GSK✓SelectedUSD · GSKCBRS vs GSK performance historyLatest closeAs of+11.22%11/13
Stock and ETF performance explorer

CBRS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-65.0%
GSK return
+1.2%
Excess return
-66.2%
Maximum drawdown
-73.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+11.2%+0.5%+10.7%+11.4%
7D+21.2%+1.1%+20.1%+21.6%
30D-23.2%+6.3%-29.5%-20.9%
3M-52.9%+1.8%-54.7%-51.9%
All-65.0%+1.2%-66.2%-64.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling